Creative Biolabs has the capability to identify or construct T-cell receptors binding various tumor-associated antigens (TAAs), such as MART-1, gp100, NY-ESO-1, MAGE antigens and carcinoembryonic antigen (CEA), with optimal affinity to meet your specific development goal of adoptive T-cell therapy of cancers. Creative Biolabs provides TCR against cancer service.
https://www.creative-biolabs.com/car-t/tcr-against-cancer.htm